Joint Pain News and Research

RSS

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue.

6 Oct 2021

Study finds even individuals with mild COVID-19 suffer from long-COVID

Researchers explored the possible risk factors for the development and persistence of longer post-COVID-19 sequelae.

29 Sep 2021

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

A recent study supports the efficacy of the mRNA-1273 vaccine in preventing COVID-19 illness and disease severity.

24 Sep 2021

Long-term effects of COVID-19 in children

A recent preprint deals with the incidence and importance of long COVID in children.

23 Sep 2021

V-safe: How everyday people help the CDC track covid vaccine safety with their phones

Of the 203 million people who have received at least one dose of a covid-19 vaccine, more than 9 million have enrolled in a program to share information about their health since getting the shot.

7 Sep 2021

Researchers explore the fate of dietary fructose in the body

In today's fast-paced world, the dependence on the widely available "fast" foods and beverages has risen. These foods are typically low in fiber and essential nutrients, and often consist of high amounts of added sugar. This shift in dietary trends, accompanied by a sedentary lifestyle, has been attributed to the rise in various metabolic disorders like diabetes, fatty liver disease, and heart disease.

31 Aug 2021

New AHA Presidential Advisory addresses opioid use and its effects on heart and brain health

The misuse of opioids in the United States continues to lead to high rates of dependency as well as a staggering number of deaths due to overdose.

19 Aug 2021

FDA approves an intravenous medication to treat patients with Pompe disease

Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.

6 Aug 2021

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

A new study from Japan, released as a medRxiv* preprint, describes the adverse effects associated with the vaccine. Such data is crucial in delineating the safety and efficacy of this intervention in various age groups.

6 Aug 2021

Flu vaccine may provide vital protection against COVID-19, study shows

In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.

4 Aug 2021

Novel type of cellular therapy safe for knee pain caused by osteoarthritis, study confirms

A study released in STEM CELLS Translational Medicine has confirmed the safety of a novel type of cellular therapy for knee pain caused by osteoarthritis.

3 Aug 2021

Poll: Reduced activity during the pandemic may have increased older adults' fall risk

The COVID-19 pandemic may have increased older adults' risk of falling and injuring themselves, due to changes in physical activity, conditioning and mobility, a new national poll suggests.

3 Aug 2021

New study disproves suspicion that dengue raises risk of zika-related microcephaly

A pregnant woman infected by zika virus does not face a greater risk of giving birth to a baby with microcephaly if she has previously been exposed to dengue virus, according to a Brazilian study that compared data for pregnant women in Rio de Janeiro and Manaus.

20 Jul 2021

Joint Pain News and Research

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Study finds even individuals with mild COVID-19 suffer from long-COVID

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

Long-term effects of COVID-19 in children

V-safe: How everyday people help the CDC track covid vaccine safety with their phones

Researchers explore the fate of dietary fructose in the body

New AHA Presidential Advisory addresses opioid use and its effects on heart and brain health

FDA approves an intravenous medication to treat patients with Pompe disease

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Flu vaccine may provide vital protection against COVID-19, study shows

Novel type of cellular therapy safe for knee pain caused by osteoarthritis, study confirms

Poll: Reduced activity during the pandemic may have increased older adults' fall risk

New study disproves suspicion that dengue raises risk of zika-related microcephaly

$50,000 grant to help explore the use of turmeric for reducing joint pain in breast cancer patients

Women at higher risk of post-COVID-19 syndrome

Exploring young people’s perspectives on patient-reported outcome measures in inflammatory arthritis

Device makers have funneled billions to orthopedic surgeons who use their products

Myocarditis after SARS-CoV-2 vaccine

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News